ArticleThe oncologist2022

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

Jonathan Thouvenin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.